Catalyst Wire Dossier Catalyst Wire Dossier

Bulevirtide (Hepcludex)

bulevirtide · Gilead Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Bulevirtide (Hepcludex), covering 2025-09-18 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Bulevirtide in Participants With Chronic Hepatitis D Infection

See pricing